tradingkey.logo
tradingkey.logo
Search

Charles River Laboratories International Inc

CRL
Add to Watchlist
356.340USD
-0.930-0.26%
Market hours 10/27, 12:35(ET)
17.01BMarket Cap
LossP/E TTM

Today

-0.26%

5 Days

+18.77%

1 Month

+21.68%

6 Months

+109.86%

Year to Date

+78.63%

1 Year

+80.85%

Key Figures

355.025Open
359.890High
107.80KVolume
LossP/E TTM
27.53P/E Dynamic
--Dividend TTM
0.23%Turnover Ratio
357.270Prev. Close
345.890Low
38.37MTurnover
1652.10P/E Static
5.99P/B
0.00%Div Yield TTM
-2.39%ROA
359.89052wk High
0.13Volume Ratio
10.30MNet Profit
47.74MShares
-3.7180EPS TTM
1.46Beta
-6.02%ROE
146.20052wk Low
3.92%Amplitude
36.29%Gross Margin
17.01BMarket Cap
10.50Reward/Risk
2.90%Risk Rate

Charles River Laboratories International Inc's Score

0.01vs previous score
Forecast8.21
Financial Health6.56
Technical4.68
Valuation Dimensions9.76
Institutional Confidence10.00
Risk Assessment6.35

Media Coverage

Coverage Level

Very Low
Very High
Positive+

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
313.738Target Price
-12.18%Upside Space
Current Rating2026-102026-092026-082026-072026-062026-052026-042026-03
Strong Buy66456666
Buy89887655
Hold44667888
Sell00000000
Strong Sell00000000

Charles River Laboratories International Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D
Technical Indicators
Buy
Summary
Buy
Moving Average
Strong buy

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
2026-11-04
Reporting Period
2026Q2
Earnings / Forecast
-0.03/2.74
Revenue / Forecast
1.00B/975.69M

Charles River Laboratories International Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolCRL
Number of employees18600
CountryUnited States of America

Ownership

ShareholdersProportion
Vanguard Capital Management, LLC6.65%
BlackRock Institutional Trust Company, N.A.5.97%
Vanguard Portfolio Management, LLC4.76%
Allspring Global Investments, LLC4.14%
Shareholder TypesProportion
Investment Advisor50.79%
Investment Advisor/Hedge Fund50.41%
Hedge Fund9.44%
Research Firm2.78%

FAQs

What is the current price of Charles River Laboratories International Inc (CRL)?

The current price of Charles River Laboratories International Inc (CRL) is 357.27.

What is the symbol of Charles River Laboratories International Inc?

The ticker symbol of Charles River Laboratories International Inc is CRL.

What is the 52-week high of Charles River Laboratories International Inc?

The 52-week high of Charles River Laboratories International Inc is 357.77.

What is the 52-week low of Charles River Laboratories International Inc?

The 52-week low of Charles River Laboratories International Inc is 146.20.

What is the market capitalization of Charles River Laboratories International Inc?

The market capitalization of Charles River Laboratories International Inc is 17.06B.

Is Charles River Laboratories International Inc (CRL) currently rated as Buy, Hold, or Sell?

According to analysts, Charles River Laboratories International Inc (CRL) has an overall rating of Buy, with a price target of 313.74.

What is the Earnings Per Share (EPS TTM) of Charles River Laboratories International Inc (CRL)?

The Earnings Per Share (EPS TTM) of Charles River Laboratories International Inc (CRL) is -3.72.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.